| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 69680-115-00 | 69680-115 | HUMAN PRESCRIPTION DRUG | Aminocaproic Acid | Aminocaproic Acid | TABLET | ORAL | 20181203 | N/A | ANDA | ANDA209060 | Vitruvias Therapeutics | AMINOCAPROIC ACID | 500 mg/1 | 100 TABLET in 1 BOTTLE (69680-115-00) |
| 69680-115-30 | 69680-115 | HUMAN PRESCRIPTION DRUG | Aminocaproic Acid | Aminocaproic Acid | TABLET | ORAL | 20181203 | N/A | ANDA | ANDA209060 | Vitruvias Therapeutics | AMINOCAPROIC ACID | 500 mg/1 | 30 TABLET in 1 BOTTLE (69680-115-30) |
| 69680-116-00 | 69680-116 | HUMAN PRESCRIPTION DRUG | Aminocaproic Acid | Aminocaproic Acid | TABLET | ORAL | 20181203 | N/A | ANDA | ANDA209060 | Vitruvias Therapeutics | AMINOCAPROIC ACID | 1000 mg/1 | 100 TABLET in 1 BOTTLE (69680-116-00) |
| 69680-116-30 | 69680-116 | HUMAN PRESCRIPTION DRUG | Aminocaproic Acid | Aminocaproic Acid | TABLET | ORAL | 20181203 | N/A | ANDA | ANDA209060 | Vitruvias Therapeutics | AMINOCAPROIC ACID | 1000 mg/1 | 30 TABLET in 1 BOTTLE (69680-116-30) |
| 60687-739-25 | 60687-739 | HUMAN PRESCRIPTION DRUG | Aminocaproic Acid | Aminocaproic Acid | TABLET | ORAL | 20230310 | N/A | ANDA | ANDA209060 | American Health Packaging | AMINOCAPROIC ACID | 500 mg/1 | 30 BLISTER PACK in 1 CARTON (60687-739-25) / 1 TABLET in 1 BLISTER PACK (60687-739-95) |